Outcomes in Patients 65 Years or Older Treated with Trimodality Therapy for Esophageal Carcinoma
β Scribed by N.K. Malik; S. Patil; A. Groman; H. Nava; S. Yendamuri; S. Nurkin; T. Sher; G. Warren; G. Yang; K. May
- Book ID
- 118456534
- Publisher
- Elsevier Science
- Year
- 2011
- Tongue
- English
- Weight
- 41 KB
- Volume
- 81
- Category
- Article
- ISSN
- 0360-3016
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
In the present study, the expression of cyclin D1, as detected by immunohistochemistry, was compared with other prognostic variables and its prognostic impact was evaluated in a group of 172 patients with squamous cell carcinoma (SCC) of the esophagus who underwent potentially curative resection the
## Abstract ## BACKGROUND Elderly patients (age β₯ 65 years) with acute myeloid leukemia (AML) generally have a poor prognosis. AMLβtype therapy results are often derived from studies in younger patients and may not apply to elderly AML. Many investigators and oncologists advocate, at times, only s